Down-regulation of eIF5A-2 prevents epithelial-mesenchymal transition in non-small-cell lung cancer cells

Journal of Zhejiang University: Science B

Volumn 14, Issue 6, 2013, Pages 460-467

  Xu, Guo Dong ^a   Shi, Xin Bao ^a   Sun, Le Bo ^a   Zhou, Qing Yun ^a   Zheng, Da Wei ^a   Shi, Huo Shun ^a   Che, Yong Liang ^a   Wang, Zi Shan ^a   Shao, Guo Feng ^a  

^a NINGBO UNIVERSITY   (China)

Author keywords

A549; Epithelial mesenchymal transition (EMT); Eukaryotic initiation factor 5A 2 (eIF5A 2); Non small cell lung cancer (NSCLC); Transforming growth factor (TGF) 1

Indexed keywords

INITIATION FACTOR 5A; INITIATION FACTOR 5A 2; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER CELL; CELL MIGRATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR CELL; TUMOR INVASION; UPREGULATION;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE KNOCKDOWN TECHNIQUES; HUMANS; PEPTIDE INITIATION FACTORS; RNA-BINDING PROTEINS;

EUKARYOTA;

EID: 84879286217     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1200200     Document Type: Article

References (21)

1. Chen, W., Luo, J.H., Hua, W.F., Zhou, F.J., Lin, M.C., Kung, H.F., Xie, D., 2009. Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy. Cancer Epidemiol. Biomarkers Prev., 18(2):400-408. [doi:10.1158/1055-9965.EPI- 08-0754]
2. Clement, P.M., Hanauske-Abel, H.M., Wolff, E.C., Kleinman, H.K., Park, M.H., 2002. The antifungal drug ciclopirox inhibits deoxyhypusine and proline hydroxylation, endothelial cell growth and angiogenesis in vitro. Int. J. Cancer, 100(4):491-498. [doi:10.1002/ijc.10515]
3. Clement, P.M., Henderson, C.A., Jenkins, Z.A., Smit-McBride, Z., Wolff, E.C., Hershey, J.W., Johansson, H.E., 2003. Identification and characterization of eukaryotic initiation factor 5A-2. Eur. J. Biochem., 270(21):4254-4263. [doi:10.1046/j.1432-1033.2003.03806.x]
4. Clement, P.M., Johansson, H.E., Wolff, E.C., Park, M.H., 2006. Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells. FEBS J., 273(6):1102-1114. [doi:10. 1111/j.1742-4658.2006.05135.x]
5. Grünert, S., Jechlinger, M., Beug, H., 2003. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell Biol., 4(8): 657-665. [doi:10.1038/nrm1175]
6. Guan, X.Y., Fung, J.M., Ma, N.F., Lau, S.H., Tai, L.S., Xie, D., Sham, J.S., 2004. Oncogenic role of eIF-5A2 in the development of ovarian cancer. Cancer Res., 64(12): 4197-4200. [doi:10.1158/0008-5472.CAN-03-3747]
7. He, L.R., Zhao, H.Y., Li, B.K., Liu, Y.H., Liu, M.Z., Guan, X.Y., Xie, D., 2011. Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients. Int. J. Cancer, 129(1):143-150. [doi:10.1002/ijc.25669]
8. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., Thun, M.J., 2008. Cancer statistics, 2008. CA Cancer J. Clin., 58(2):71-96. [doi:10.3322/CA.2007.0010]
9. Kasai, H., Allen, J.T., Mason, R.M., Kamimura, T., Zhang, Z., 2005. TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir. Res., 6(1):56. [doi:10.1186/1465-9921-6-56]
10. Kim, J.H., Jang, Y.S., Eom, K.S., Hwang, Y.I., Kang, H.R., Jang, S.H., Kim, D.G., 2007. Transforming growth factor β1 induces epithelial-to- mesenchymal transition of A549 cells. J. Korean Med. Sci., 22(5):898-904. [doi:10.3346/jkms.2007.22.5.898]
11. Li, A.L., Li, H.Y., Jin, B.F., Ye, Q.N., Zhou, T., Yu, X.D., Zhang, X.M., 2004. A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosis. J. Biol. Chem., 279(47):49251-49258. [doi:10.1074/jbc.M407165200]
12. Maitah, M.Y., Ali, S., Ahmad, A., Gadgeel, S., Sarkar, F.H., 2011. Up-regulation of sonic hedgehog contributes to TGF-β1-induced epithelial to mesenchymal transition in NSCLC cells. PLoS One, 6(1):e16068. [doi:10.1371/journal.pone.0016068]
13. Nishimura, K., Murozumi, K., Shirahata, A., Park, M.H., Kashiwagi, K., Igarashi, K., 2005. Independent roles of eIF5A and polyamines in cell proliferation. Biochem. J., 385(Pt3):779-785. [doi:10.1042/BJ20041477]
14. Nozawa, N., Hashimoto, S., Nakashima, Y., Matsuo, Y., Koga, T., Sugio, K., Sueishi, K., 2006. Immunohistochemical α- and β-catenin and E-cadherin expression and their clinicopathological significance in human lung adenocarcinoma. Pathol. Res. Pract., 202(9):639-650. [doi:10.1016/j. prp.2006.03.007]
15. Rosell, R., Felip, E., Taron, M., Majo, J., Mendez, P., Sanchez-Ronco, M., Maestre, J., 2004. Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery. Clin. Cancer Res., 10(12):4215s-4219s. [doi:10.1158/1078-0432.CCR-040006]
16. Saito, R.A., Watabe, T., Horiguchi, K., Kohyama, T., Saitoh, M., Nagase, T., Miyazono, K., 2009. Thyroid transcription factor-1 inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells. Cancer Res., 69(7):2783-2791. [doi:10.1158/0008-5472.CAN- 08-3490]
17. Tang, D.J., Dong, S.S., Ma, N.F., Xie, D., Chen, L., Fu, L., Guan, X.Y., 2010. Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma. Hepatology, 51(4):1255-1263. [doi:10.1002/hep.23451]
18. Thiery, J.P., 2002. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer, 2(6):442-454. [doi:10.1038/nrc822]
19. Wozniak, A.J., Gadgeel, S.M., 2007. Adjuvant treatment of non-small-cell lung cancer: how do we improve the cure rates further? Oncology, 21(2):163-171.
20. Xie, D., Ma, N.F., Pan, Z.Z., Wu, H.X., Liu, Y.D., Wu, G.Q., Guan, X.Y., 2008. Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma. Hum. Pathol., 39(1):80-86. [doi:10.1016/j.humpath.2007.05. 011]
21. Yang, G.F., Xie, D., Liu, J.H., Luo, J.H., Li, L.J., Hua, W.F., Guan, X.Y., 2009. Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma. Gynecol. Oncol., 112(2):314-318. [doi:10.1016/j.ygyno.2008.10.024]